Phospho-RAF1 (Ser339) Polyclonal Antibody, APC Conjugated

CAT:
498-bs-5652R-APC-01
Size:
20 µL
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Phospho-RAF1 (Ser339) Polyclonal Antibody, APC Conjugated - image 1

Phospho-RAF1 (Ser339) Polyclonal Antibody, APC Conjugated

  • Background:

    Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2) . The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1) . Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation.
  • Synonyms:

    NS5; CRAF; Raf-1; c-Raf; CMD1NN; RAF proto-oncogene serine/threonine-protein kinase; Proto-oncogene c-RAF; RAF1; RAF
  • Gene ID:

    5894
  • Swiss Prot:

    P04049
  • Modification Site:

    Ser339
  • Cellular Locus:

    Cytoplasm, Nucleus, Cell membrane
  • Host:

    Rabbit
  • Cross Reactivity:

    Human, Mouse
  • Target:

    Phospho-RAF1 (Ser339)
  • Clonality:

    Polyclonal
  • Isotype:

    IgG
  • Conjugation:

    APC
  • Source:

    KLH conjugated synthetic phosphopeptide derived from human c-Raf around the phosphorylation site of Ser339
  • Applications:

    WB, IF (IHC-P), IF (IHC-F), IF (ICC)
  • Purification:

    Purified by Protein A.
  • Excitation Emission:

    650nm/660nm
  • Concentration:

    1µg/µl
  • Dilution:

    WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
  • Buffer:

    Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
  • Modification:

    Phosphorylation
  • Storage Conditions:

    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
  • Gene ID URL:

    5894
  • Predicted Cross Reactivity:

    Rat, Dog, Cow, Sheep, Pig, Horse, Chicken, Rabbit